Revvity (NYSE:RVTY) Sets New 1-Year High – Here’s What Happened

Shares of Revvity Inc. (NYSE:RVTY – Get Free Report) hit a new 52-week high during mid-day trading on Wednesday. The stock traded as high as $168.66 and last traded at $168.11, with a volume of 417,463 shares. The stock had previously closed at $161.86.

Analyst Ratings Changes

Several research firms have commented on RVTY. Zacks Research raised Revvity from a “strong sell” rating to a “hold” rating in a research report on Tuesday, August 4th. TD Cowen increased their price objective on Revvity from $130.00 to $175.00 and gave the company a “buy” rating in a report on Tuesday, October 13th. Weiss Ratings upgraded shares of Revvity from a “hold (c-)” rating to a “hold (c)” rating in a research report on Thursday, October 8th. Barclays lifted their target price on shares of Revvity from $115.00 to $160.00 and gave the company an “equal weight” rating in a report on Wednesday, October 7th. Finally, UBS Group initiated coverage on shares of Revvity in a research report on Wednesday, September 9th. They issued a “neutral” rating and a $140.00 price target for the company. Five equities research analysts have rated the stock with a Buy rating and thirteen have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, Revvity presently has an average rating of “Hold” and an average target price of $124.43.

Check Out Our Latest Report on RVTY

Revvity Trading Up 2.8%

The firm has a market capitalization of $18.57 billion, a price-to-earnings ratio of 79.27 and a beta of 1.06. The stock’s 50 day moving average price is $141.93 and its two-hundred day moving average price is $111.26.

Revvity (NYSE:RVTY – Get Free Report) last released its quarterly earnings data on Tuesday, August 4th. The company reported $1.41 earnings per share for the quarter, beating the consensus estimate of $1.21 by $0.20. The firm had revenue of $729.69 million during the quarter, compared to analysts’ expectations of $702.96 million. The business’s revenue for the quarter was down 1.3% on a year-over-year basis. During the same period in the previous year, the business earned $1.18 earnings per share. Revvity has set its FY 2026 guidance at 5.300-5.400 EPS. On average, sell-side analysts forecast that Revvity Inc. will post 5.36 earnings per share for the current fiscal year.

Revvity Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, November 13th. Shareholders of record on Friday, October 23rd will be paid a dividend of $0.07 per share. This represents a $0.28 annualized dividend and a dividend yield of 0.2%. The ex-dividend date of this dividend is Friday, October 23rd. Revvity’s dividend payout ratio (DPR) is currently 13.33%.

Insider Activity at Revvity

In related news, insider Tajinder Vohra sold 7,330 shares of the stock in a transaction dated Wednesday, September 16th. The stock was sold at an average price of $140.88, for a total transaction of $1,032,650.40. Following the transaction, the insider directly owned 6,635 shares in the company, valued at approximately $934,738.80. This represents a 52.49% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, insider Maxwell Krakowiak sold 1,631 shares of the stock in a transaction dated Monday, September 21st. The stock was sold at an average price of $144.53, for a total transaction of $235,728.43. Following the transaction, the insider owned 14,781 shares in the company, valued at approximately $2,136,297.93. The trade was a 9.94% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 9,045 shares of company stock valued at $1,281,439 over the last ninety days. 0.85% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On Revvity

A number of hedge funds have recently made changes to their positions in the stock. Asset Management One Co. Ltd. increased its holdings in shares of Revvity by 4.1% during the 3rd quarter. Asset Management One Co. Ltd. now owns 5,525 shares of the company’s stock worth $845,000 after buying an additional 219 shares during the last quarter. Leslie Global Wealth LLC acquired a new position in Revvity in the third quarter valued at $306,000. Apollon Wealth Management LLC boosted its holdings in Revvity by 2.7% in the third quarter. Apollon Wealth Management LLC now owns 2,778 shares of the company’s stock valued at $425,000 after acquiring an additional 73 shares during the last quarter. Signaturefd LLC grew its holdings in shares of Revvity by 49.6% during the 3rd quarter. Signaturefd LLC now owns 1,408 shares of the company’s stock worth $215,000 after purchasing an additional 467 shares during the period. Finally, Inspire Investing LLC grew its stake in Revvity by 20.3% during the third quarter. Inspire Investing LLC now owns 7,196 shares of the company’s stock worth $1,100,000 after buying an additional 1,215 shares during the period. Institutional investors and hedge funds own 86.65% of the company’s stock.

Revvity Company Profile

(Get Free Report)

Revvity, Inc provides technology, products and services for the life sciences and diagnostics markets. The company supports pharmaceutical and biotechnology research, clinical laboratories and other healthcare organizations with tools used in drug discovery, biological research, disease detection and laboratory testing.

Its offerings include laboratory instruments, reagents, consumables, software and workflow solutions. Key areas include genomics, proteomics, cellular analysis, imaging, screening, automation and reproductive health, as well as newborn screening and other diagnostic applications.

Featured Articles

Receive News & Ratings for Revvity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Revvity and related companies with MarketBeat.com's FREE daily email newsletter.